Recently Viewed
Clear AllBidding Date
16-Sep-2024 to
19-Sep-2024
Issue Size
₹410 Cr
Price Band
₹121 to ₹128
Allotment date
20-Sep-2024
Listing date
24-Sep-2024
Lot size
110
No. of shares
3,20,31,250
Fresh issue/OFS
₹410 Cr /--
Established as a company in redevelopment projects, Arkade Developers Ltd has completed numerous projects since its inception, benefiting from the family’s real estate legacy dating back to 1986. The company operates in two main categories: the development of new residential projects and the redevelopment of existing premises. Its focus on premium budget, aesthetically designed homes with lifestyle amenities has led to the completion of 28 projects over the past two decades, totaling over 4.5 million square feet of developed space. The company primarily operates in Mumbai, one of India’s most expensive real estate markets, with a significant presence in the western suburbs, including Borivali West, Goregaon East, and Santacruz West. It has successfully completed 10 redevelopment projects in the western suburbs and 1 project in south-central Mumbai.
Read our in-depth analysis of the Arkade Developers Ltd IPO Here
Category
Status
QIBs
163.2x
NIIs
162.4x
Retail
49.8x
Others
48.8x
Total
105.9x
The issue size of Arkade Developers is ₹410.00 Cr.
Arkade Developers falls into Real Estate Management & Development industry.
The Arkade Developers IPO will be listed on both NSE and BSE.
The open and close dates for the Arkade Developers are 16-Sep-2024 & 19-Sep-2024.
The price band for the Arkade Developers ipo is ₹121 to ₹128
The listing date of Arkade Developers IPO is 24-Sep-2024.
The purpose of this IPO is to raise fresh capital.
Arkade Developers total subscription ratio is 105.9X.
Key financial of the Arkade Developers are:
| Arkade Developers | FY-24 | FY-23 | FY-22 |
|---|---|---|---|
| Revenue (₹ Cr) | 634.74 | 220.15 | 228.94 |
| EBIT (₹ Cr) | 166.3 | 66.64 | 54.37 |
| Proft after Tax (₹ Cr) | 122.91 | 50.77 | 50.84 |
| Debt (₹ Cr) | 69.41 | 149 | 64.41 |
| Net Worth (₹ Cr) | 323.63 | 200.37 | 149.3 |
| RoE (%) | 37.98 | 25.34 | 34.06 |